Loading…
CPHI
China Pharma Holdings Inc
NYSE American· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP 16941T401
$0.90+2.03%Price as of Aug 29, 18:41 UTC · updated once a day, after the close
Key metrics
- Market cap
- $38.9M
- P/E
- —
- Forward P/E
- —
- P/B
- 1.0x
- Dividend yield
- —
- Payout
- —
- EPS
- -$0.42
- ROE
- -20.99%
- Profit margin
- -114.33%
- Revenue growth
- -7.50%
- Beta
- 1.07
- 52-week high
- $19.19
- 52-week low
- $0.38
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -99.8% over 5Y.
today you would have $2.68▼ -99.7%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 16 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $1.21 | $2.30 | $6.00 | $50.00 | $240.00 | $225.00 | $120.00 | $130.00 | $90.00 | $130.00 | $80.00 | $150.00 | $175.00 | $100.00 | $335.00 | $1,515.00 | |
| P/E | 1.8x |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ELUTElutia Inc | $0.88 | — | 2.5x | — | — | $38.97M |
| CRVOCervoMed Inc. | $2.60 | — | 1.5x | — | -107.62% | $39.31M |
| DCGODocGo Inc. | $0.40 | — | 0.3x | — | -107.79% | $39.32M |
| PAVMPAVmed Inc. | $4.92 | — |
About the company
China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection for edema diseases, hypertension, acute renal failure, hyperkalemia, hypercalcemia, and acute drug poisoning; and Candesartan for hypertension. It offers Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and Pseudophedrine Hydrochlorida sustained release tablets, as well as Hepatocyte growth-promoting factors, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. In addition, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection for nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It supplies its products to hospitals and OTC pharmacies through provincial and municipal pharmaceutical logistics companies. The company is based in Haikou, the People's Republic of China.
- 215
- Haikou, China
Company description provided by Yahoo Finance.